Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...

Johnson & Johnson said Wednesday that new data from early trials of a booster shot of its COVID-19 vaccine provides a "rapid and robust increase in spike-binding antibodies" that fight off the virus.

A top doctor is pushing back against a panel of experts' decision to delay voting on a recommendation to give to the Centers for Disease Control and Prevention regarding the Johnson & Johnson COVID-19 ...